[Spontaneous ecchymosis disclosing acquired factor VIII inhibitor]. 1993

O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
Service de Médecine Interne, Centre d'Allergie, Hôpital Rothschild, Paris.

An 81-year old woman suddenly developed extensive ecchymosis. A factor VIII:c inhibitor was detected. She received porcine factor VIII, corticosteroids, intravenous immunoglobulins and cyclophosphamide. Normalization of factor VIII level was achieved in 1 month. The patient died, 3 months later, of congestive heart failure. Spontaneous development of factor VIII inhibitors is an extremely rare event which usually occurs in dramatic bleeding. Many associated diseases have been reported. Patients with serious bleeding should be given porcine factor VIII. Immunosuppressive therapy consists of corticosteroids, cyclophosphamide and intravenous immunoglobulins.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D004438 Ecchymosis Extravasation of blood into the skin, resulting in a nonelevated, rounded or irregular, blue or purplish patch, larger than a petechia. Ecchymoses
D005130 Eye Hemorrhage Intraocular hemorrhage from the vessels of various tissues of the eye. Hemophthalmos,Hemorrhage, Eye,Eye Hemorrhages
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
November 1991, The Journal of the Kentucky Medical Association,
O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
November 2009, Anesthesiology,
O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
January 2015, Medicina,
O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
May 2011, Southern medical journal,
O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
September 2004, The American surgeon,
O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
July 2010, Arthritis care & research,
O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
October 1995, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
March 1983, The West Virginia medical journal,
O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
April 2018, Journal of cardiothoracic and vascular anesthesia,
O Bayrou, and A Deschamps, and C Laurian, and C Braunstein, and F Leynadier
May 1989, Annals of internal medicine,
Copied contents to your clipboard!